The loss compares with net income of $111 million in the same period ending Sept. 30, 2021.
The company also reported a net loss of $369 million for the nine months ending Sept. 30 compared with net income of $52 million for the same period in 2021.
CHS lost operating revenues and incurred incremental expenses of approximately $10 million as a direct result of Hurricane Ian, which affected some of its facilities in Florida when it made landfall in late September. That figure could be adjusted once insurance issues are considered, the company said.
In addition, CHS received $108 million in pandemic-related relief during the third quarter and $160 million in relief through the first nine months of the year.
CHS operates across 16 states with 81 acute care hospitals and more than 1,000 other clinical sites.
More details on the results can be found here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
